What's the root cause of PAB's poor SP performance?, page-21

Its a specy. Lots of variables. If the trial is successful it will go gangbusters.

I think one problem with PAB is that they aren't directly in control of these basic functions. ie. the manufacture of PAT-SM6, in USA, they have to accept the progress of the third party.

They had trouble with the manufacture a few months ago and said it was fixed, but there could be another problem.

Please correct me if Im wrong, but doesnt PAB use plants to create the antibodies and controls which antibodies are created by modifying the sugars ? ie. glycoengineering

PaB is the first to develop this technique. Its produces alot of antibodies and does it very cheaply.

Its revolutionary and super-cheap ! and so far doesnt seem to work very well....

Its funny the effecttiveness doesnt seem to be the problem, its making the stuff !